polyglyceryl-4 caprylate est-il sûr pendant la grossesse ?
No harmonised CLP classification or SCCS/CIR reproductive warnings were found; CIR family safety assessment for polyglyceryl fatty‑acid esters reports no reproductive toxicity data and treats these esters as low‑hazard cosmetic emulsifiers, and ECHA registration pages indicate no need for classification for mutagenicity or sensitisation. There are no peer‑reviewed reproductive or teratogenic studies for polyglyceryl‑4 caprylate identified. (Sources: CIR family report; ECHA dossier; PubChem/EPA entries).
Pregnancy-safe products containing polyglyceryl-4 caprylate










Related ingredients
Frequently asked questions
- polyglyceryl-4 caprylate est-il sûr pendant la grossesse ?
- No harmonised CLP classification or SCCS/CIR reproductive warnings were found; CIR family safety assessment for polyglyceryl fatty‑acid esters reports no reproductive toxicity data and treats these esters as low‑hazard cosmetic emulsifiers, and ECHA registration pages indicate no need for classification for mutagenicity or sensitisation. There are no peer‑reviewed reproductive or teratogenic studies for polyglyceryl‑4 caprylate identified. (Sources: CIR family report; ECHA dossier; PubChem/EPA entries).
- polyglyceryl-4 caprylate est-il sûr pendant l'allaitement ?
- No data indicating reproductive/developmental or lactation transfer concerns; no harmonised classifications (H361/H360) or regulatory bans found. By default, absent evidence of reproductive hazard and given the ingredient’s use as a topical emulsifier, hazard and mechanism are scored 0. (Sources: ECHA registration information; CIR assessment; PubChem/EWG summaries).
- polyglyceryl-4 caprylate est-il sûr pour la peau de bébé ?
- Hazard and mechanism remain 0 (no evidence of reproductive/endocrine hazard). Exposure (e) is increased by +1 for 0–3‑yr skin per instruction because infant skin has a higher surface‑area‑to‑weight ratio and immature barrier and the ingredient is not an absolutely non‑absorbable inorganic — however available data (CIR/ECHA summaries) indicate low systemic availability from topical use. No infant‑specific toxicokinetic or developmental toxicity data were found. (Sources: CIR family report; ECHA registration; EWG ingredient page).
- Comment VeriMom évalue-t-il polyglyceryl-4 caprylate ?
- VeriMom évalue polyglyceryl-4 caprylate à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à polyglyceryl-4 caprylate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à polyglyceryl-4 caprylate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.